Replies to post #2506 on Acadia Pharmaceuticals Inc. (ACAD)

[IanFromSI]

Seems as if more of the free 30 day trials are being converted to paid tx than had been expected.

Be nice to see an approval for AD...

ACADIA Pharmaceuticals Q2 Results Top Estimates, Shares Jump After-Hours

2017-08-08 05:59:21 PM ET (MT Newswires)



05:59 PM EDT, 08/08/2017 (MT Newswires) -- ACADIA Pharmaceuticals' (ACAD) Q2 net loss narrowed to $0.55 per share from net loss of $0.63 per share a year earlier, better than analysts' estimate of a net loss of $0.72 per share in a Capital IQ poll, sending its shares up over 11% in after-hours trading.


Revenues jumped to $30.48 million from $97,000 a year ago, also sharply higher than the $20.02 million estimate.


Price: 32.90, Change: +3.36, Percent Change: +11.37